Abstract：Objective To evaluate the radiosensitizing effect and action mechanism of a tyrosine kinase inhibitor, ARQ197, on lung cancer cell line H1299. Methods H1299 cells were treated with different concentrations of recombinant human hepatocyte growth factor (HGF) and ARQ197, respectively. Colony formation assay was used to investigate the proliferation of H1299 cells, and the optimal concentrations of HGF and ARQ197 were figured out for the radiosensitivity study. H1299 cells were divided into control, HGF-treated, ARQ197-treated, and HGF+ARQ197-treated groups, and the differences between those groups were evaluated. The impacts of HGF, radiation alone, or HGF+ARQ197 on the expression and activation of c-Met and the downstream Akt and Erk1/2 were determined by Western blot. Results The colony formation rate of H1299 cells increased with increasing HGF concentration, and decreased with increasing ARQ197 concentration. Using the linear-quadratic model, the cell survival curve showed that the radiation dose enhancement ratios for H1299 cells treated with HGF, HGF+ARQ197, and ARQ197 were 0.85, 1.20, and 1.27, respectively, when the surviving fraction was 0.1. The expression of pc-Met, p-Akt, and p-Erk1/2 proteins increased in H1299 cells after HGF stimulation. In HGF+ARQ197-treated cells, the expression of pc-Met, p-Akt, and p-Erk1/2 proteins decreased with increasing ARQ197 concentration. After 2 Gy irradiation, the expression of pc-Met, p-Akt, and p-Erk1/2 proteins increased in HGF-treated cells but substantially decreased in HGF+ARQ197-treated cells, while there were no significant changes in the expression of total c-Met, Akt, and Erk1/2 proteins. Conclusions ARQ197 has a substantial radiosensitizing effect on lung cancer cell line H1299 in vitro by inhibiting HGF/c-Met and activation of downstream signaling pathways.
Shan Fang*,Zhang Jingdi,Chen Liesong et al. Radiosensitizing effect of ARQ197, a small-molecule tyrosine kinase inhibitor of c-Met, on lung cancer cell line H1299[J]. Chinese Journal of Radiation Oncology, 2015, 24(5): 588-592.
[1] Blumenschein Jr GR, Mills GB, Gonzalez-Angulo AM. Targeting the hepatocyte growth factor-cMET axis in cancer therapy[J]. J Clin Oncol,2012,30(26):3287-3296.DOI:10.1200/JCO.2011.40.3774. [2] Preusser M, Streubel B, Berghoff AS, et al. Amplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancer[J]. Histopath, 2014, 65(5):684-692. DOI:10.1111/his.12475. [3] Bhardwaj V, Cascone T, Cortez MA, et al. Modulation of c-Met signalling and cellular sensitivity to radiation:potential implications for therapy[J]. Cancer,2013,119(10):1768-1775.DOI:10.1002/cncr.27965. [4] Zhang YW, Su Y, Volpert OV, et al. Hepatocyte growth factor scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin l regulation[J]. Proc Natl Acad Sci USA,2003,100(22):12718-12723. [5] Kim KJ, Wang L, Su Y, et a1. Systematic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma[J]. Clin Cancer Res 2006,12(4):1292-1298. [6] Blumenschein Jr GR, Mills GB, Gonzalez-Angulo AM. Targeting the hepatocyte growth factor-cMET axis in cancer therapy[J]. J Clin Oncol,2012,30(26):3287-3296.DOI:10.1200/JCO.2011.40.3774. [7] De Bacco F, Luraghi P, Medico E, et al. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer[J].J Natl Cancer Inst,2011,103(8):645-661.DOI:10.1093/jnci/djr093. [8] Yang H, Lee HW, Kim Y, et al. Radiosensitization of brain metastasis by targeting c-MET[J]. Lab Investigation,2013,93(3):344-353.DOI:10.1038/labinvest.2012.180. [9] Buchanan IM, Scott T, Tandle AT, et al. Radiosensitization of glioma cells by modulation of Met signaling with the hepatocyte growth factor neutralizing antibody, AMG102[J]. J Cell Mol Med,2011,15(9):1999-2006.DOI:10.1111/j.1582-4934.2010.01122.x. [10] Li B, Torossian A, Sun Y, et al. Higher levels of c-Met expression and phosphorylation identify cell lines with increased sensitivity to AMG-458, a novel selective c-Met inhibitor with radiosensitizing effects[J]. Int J Radiat Oncol Biol Phys,2012,84(4):525-531.DOI:10.1016/j.ijrobp.2012.06.025.
2015, Vol. 24 
